Clarivate’s ‘drugs to watch’ list signals high prices to come

11-02-2020

Rory O'Neill

Clarivate’s ‘drugs to watch’ list signals high prices to come

sharafmaksumov / Shutterstock.com

Clarivate Analytics has released its annual “drug to watch” list, compiled through its Cortellis database of life sciences-focused research and development data.


Bristol-Myers Squibb, Clarivate Analytics, Cortellis, BioMarin Pharmaceutical, haemophilia A, Valrox, gene therapy, The Medicines Company

LSIPR